S. SAHIN Et Al. , "Significance of pentraxin-3 in patients with juvenile scleroderma," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, pp.221, 2017
SAHIN, S. Et Al. 2017. Significance of pentraxin-3 in patients with juvenile scleroderma. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35 , 221.
SAHIN, S., ADROVIC, A., BARUT, K., DURMUŞ, S., UZUN, H., & KASAPCOPUR, O., (2017). Significance of pentraxin-3 in patients with juvenile scleroderma. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, 221.
SAHIN, S Et Al. "Significance of pentraxin-3 in patients with juvenile scleroderma," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, 221, 2017
SAHIN, S Et Al. "Significance of pentraxin-3 in patients with juvenile scleroderma." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, pp.221, 2017
SAHIN, S. Et Al. (2017) . "Significance of pentraxin-3 in patients with juvenile scleroderma." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.35, p.221.
@article{article, author={S SAHIN Et Al. }, title={Significance of pentraxin-3 in patients with juvenile scleroderma}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2017, pages={221} }